Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?

BACKGROUND: Despite evidence that shows no survival advantage, many older patients receive primary androgen-deprivation therapy (PADT) shortly after the diagnosis of localized prostate cancer (PCa). OBJECTIVE: This study evaluates whether the early use of PADT affects the subsequent receipt of addit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lu-Yao, Grace L., Albertsen, Peter C., Li, Hui, Moore, Dirk F., Shih, Weichung, Lin, Yong, DiPaola, Robert S., Yao, Siu-Long
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472155/
https://ncbi.nlm.nih.gov/pubmed/22608160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.05.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky